Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | +0.50% | -3.90% | -83.14% |
05-09 | EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Health Care Down on Retreat From Risk -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.14% | 9.41M | |
+4.11% | 111B | |
+11.47% | 105B | |
-13.00% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.24% | 16.96B | |
+3.27% | 13.7B | |
+36.96% | 12.45B |
- Stock Market
- Equities
- EFTR Stock
- News eFFECTOR Therapeutics, Inc.
- Credit Suisse Trims eFFECTOR Therapeutics' Price Target to $5.50 From $7, Keeps Outperform Rating